Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs62052168 | chr16:89947203 | G/A | 0.000183 | 175 | 25.87 | 20.2 | 36.37 | KM Plot |
PCPG | rs62052174 | chr16:89950901 | G/A | 0.000157 | 176 | 25.77 | 21.5 | 36.37 | KM Plot |
PCPG | rs62052180 | chr16:89963289 | C/G | 0.000157 | 175 | 25.87 | 21.5 | 36.37 | KM Plot |
PCPG | rs62052183 | chr16:89966921 | C/A | 0.000157 | 175 | 25.87 | 21.5 | 36.37 | KM Plot |
PCPG | rs62052185 | chr16:89969254 | C/T | 0.000157 | 175 | 25.87 | 21.5 | 36.37 | KM Plot |
PCPG | rs62052186 | chr16:89969567 | A/T | 0.000167 | 175 | 25.87 | 20.28 | 36.37 | KM Plot |
PCPG | rs62052187 | chr16:89973071 | G/A | 0.000153 | 175 | 25.87 | 20.37 | 36.37 | KM Plot |
PCPG | rs62052189 | chr16:89975555 | G/C | 0.00018 | 173 | 25.87 | 20.28 | 36.37 | KM Plot |
PCPG | rs62052210 | chr16:89980158 | A/G | 0.000156 | 176 | 25.87 | 20.28 | 3.17 | KM Plot |
PCPG | rs62052212 | chr16:89981960 | G/A | 0.000167 | 175 | 25.87 | 20.28 | 36.37 | KM Plot |
PCPG | rs62052213 | chr16:89991963 | C/T | 1.11E-16 | 171 | 25.87 | 20.28 | 3.17 | KM Plot |
PCPG | rs62052222 | chr16:90016228 | C/G | 1.64E-8 | 170 | 25.6 | 20.17 | 6.62 | KM Plot |
PCPG | rs62052223 | chr16:90018186 | T/C | 1.64E-8 | 171 | 25.53 | 20.17 | 6.62 | KM Plot |
PCPG | rs62052226 | chr16:90022137 | T/C | 1.45E-8 | 171 | 25.67 | 20.17 | 6.62 | KM Plot |
PCPG | rs62052239 | chr16:90024866 | C/T | 1.23E-8 | 172 | 25.6 | 20.28 | 6.62 | KM Plot |